Upgrade to SI Premium - Free Trial

Seres Therapeutics (MCRB) PT Lowered to $18 at Oppenheimer

March 9, 2018 2:12 AM
Oppenheimer lowered its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles